SLC22A5 and Crohn disease: Carnitine’s role in the GI tract has recently been highlighted by several publications linking mutations in genes encoding carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5) with Crohn’s disease (CD) [23], [24], [25], [26], [27], [28], [29].